Cellestia launches a new drug discovery program to target Transcription Factors

Cellestia initiates a new drug discovery program focused on Transcription Factors which addresses unmet medical need in cancer, autoimmune and inflammatory disorders. The program is launched in collaboration with Prof. Vincent Zoete from the Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research, Lausanne and the SIB Swiss Institute of Bioinformatics and co-financed by Innosuisse.

To read the Press Release click here